🇪🇺 Leustatin in European Union

Leustatin (CLADRIBINE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/004230
  • Local brand name: Mavenclad
  • Status: approved

Leustatin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Leustatin approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Leustatin in European Union?

Marketing authorisation holder not available in our data.